Skip to main content
Erschienen in: Annals of Surgical Oncology 6/2022

22.01.2022 | Breast Oncology

Mastectomy or Margin Re-excision? A Nomogram for Close/Positive Margins After Lumpectomy for DCIS

verfasst von: Catarina Martins Maia, MD, Cleo Siderides, BA, Shabnam Jaffer, MD, Christina Weltz, MD, Sarah Cate, MD, Soojin Ahn, MD, Susan Boolbol, MD, Meng Ru, MS, Erin Moshier, MS, Elisa Port, MD, Hank Schmidt, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Anatomic extent of ductal carcinoma in situ (DCIS) may be uncertain in spite of clinical, pathologic, and imaging data. Consequently close/positive margins are common with lumpectomy for DCIS and often lead to a challenge in deciding whether to perform a re-excision or mastectomy.

Patients and Methods

From a single health system, we identified cases of lumpectomy for DCIS with close/positive margins who underwent re-excision for the purpose of constructing a nomogram. In total, 289 patients were available for analysis. The patients were randomly divided into two sets allocating 70% to the modeling and 30% to the validation set. A multivariable logistic regression model was used to estimate the probability of overall positive margin status using multiple clinicopathologic predictors. Nomogram validation included internal tenfold cross-validation, internal bootstrap validation, and external validation for which a concordance index was calculated to assess the external validity.

Results

Significant predictors of persistent positive margins from regression modeling included necrosis at diagnosis (non-comedo or comedo); DCIS not associated with calcifications on core biopsy; high-grade DCIS; progesterone receptor positivity; and number of positive margins at initial surgery. When subjected to internal validation, the nomogram achieved an uncorrected concordance index of 0.7332, a tenfold cross-validation concordance index of 0.6795, and a bootstrap-corrected concordance index of 0.6881. External validation yielded an estimated concordance index of 0.7095.

Conclusion

Using clinical and pathologic variables from initial diagnosis and surgery for DCIS, this nomogram predicts persistent positive margins with margin re-excision, and may be a valuable tool in surgical decision-making.
Literatur
1.
Zurück zum Zitat Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Correa C, McGale P, Taylor C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010(41):162–77. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Correa C, McGale P, Taylor C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010(41):162–77.
2.
Zurück zum Zitat Donker M, Litiere S, Werutsky G, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol. 2013;31:4054–9.CrossRef Donker M, Litiere S, Werutsky G, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol. 2013;31:4054–9.CrossRef
3.
Zurück zum Zitat Van Zee KJ, Subhedar P, Olcese C, et al. Relationship between margin width and recurrence of ductal carcinoma in situ: analysis SSO–ASTRO–ASCO Guideline: BCS margins in DCIS 3809 of 2996 women treated with breast-conserving surgery for 30 years. Ann Surg. 2015;262:623–33.CrossRef Van Zee KJ, Subhedar P, Olcese C, et al. Relationship between margin width and recurrence of ductal carcinoma in situ: analysis SSO–ASTRO–ASCO Guideline: BCS margins in DCIS 3809 of 2996 women treated with breast-conserving surgery for 30 years. Ann Surg. 2015;262:623–33.CrossRef
4.
Zurück zum Zitat Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: intraductal carcinoma (ductal carcinoma in situ)—The National Surgical Adjuvant Breast and Bowel Project collaborating investigators. Cancer. 1995;75:1310–9.CrossRef Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: intraductal carcinoma (ductal carcinoma in situ)—The National Surgical Adjuvant Breast and Bowel Project collaborating investigators. Cancer. 1995;75:1310–9.CrossRef
5.
Zurück zum Zitat Morrow M, Jagsi R, Alderman AK, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA. 2009;302:1551–6.CrossRef Morrow M, Jagsi R, Alderman AK, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA. 2009;302:1551–6.CrossRef
7.
Zurück zum Zitat Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001.CrossRef Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001.CrossRef
8.
Zurück zum Zitat Heymans MW, van Buuren S, Knol DL, van Mechelen W, de Vet HC. Variable selection under multiple imputation using the bootstrap in a prognostic study. BMC Med Res Methodol. 2007;13(7):33.CrossRef Heymans MW, van Buuren S, Knol DL, van Mechelen W, de Vet HC. Variable selection under multiple imputation using the bootstrap in a prognostic study. BMC Med Res Methodol. 2007;13(7):33.CrossRef
9.
Zurück zum Zitat Vickers AJ, Cronin AM, Elkin EB, et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008;8:53.CrossRef Vickers AJ, Cronin AM, Elkin EB, et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008;8:53.CrossRef
10.
Zurück zum Zitat Collins GS, Reitsma JB, Altman DG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.CrossRef Collins GS, Reitsma JB, Altman DG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.CrossRef
11.
Zurück zum Zitat Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16:e173–80.CrossRef Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16:e173–80.CrossRef
12.
Zurück zum Zitat Van Zee K, Manasseh D, Bevilacqua J, Boolbol S, Fey JV, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10(10):1140–51.CrossRef Van Zee K, Manasseh D, Bevilacqua J, Boolbol S, Fey JV, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10(10):1140–51.CrossRef
13.
Zurück zum Zitat Bevilacqua J, Kattan M, Fey J, Cody H, Borgen P, Van Zee K. Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol. 2007;25:3670–9.CrossRef Bevilacqua J, Kattan M, Fey J, Cody H, Borgen P, Van Zee K. Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol. 2007;25:3670–9.CrossRef
14.
Zurück zum Zitat Shin HC, Han W, Moon HG, et al. Nomogram for predicting positive resection margins after breast-conserving surgery. Breast Cancer Res Treat. 2012;134(3):1115–23.CrossRef Shin HC, Han W, Moon HG, et al. Nomogram for predicting positive resection margins after breast-conserving surgery. Breast Cancer Res Treat. 2012;134(3):1115–23.CrossRef
15.
Zurück zum Zitat Pleijhuis RG, Kwast AB, Jansen L, et al. A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making. Breast. 2013;22(5):773–9.CrossRef Pleijhuis RG, Kwast AB, Jansen L, et al. A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making. Breast. 2013;22(5):773–9.CrossRef
16.
Zurück zum Zitat Rath MG, Uhlmann L, Heil J, et al. Predictors of residual tumor in breast-conserving therapy. Ann Surg Oncol. 2015;22(Suppl 3):S451–8.CrossRef Rath MG, Uhlmann L, Heil J, et al. Predictors of residual tumor in breast-conserving therapy. Ann Surg Oncol. 2015;22(Suppl 3):S451–8.CrossRef
17.
Zurück zum Zitat Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 2010;28(23):3762–9.CrossRef Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 2010;28(23):3762–9.CrossRef
18.
Zurück zum Zitat Sweldens C, Peeters S, van Limbergen E, et al. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram. Cancer J. 2014;20(1):1–7.CrossRef Sweldens C, Peeters S, van Limbergen E, et al. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram. Cancer J. 2014;20(1):1–7.CrossRef
19.
Zurück zum Zitat Van Zee KJ, Zabor EC, Di Donato R, et al. Comparison of local recurrence risk estimates after breast-conserving surgery for DCIS: DCIS nomogram versus refined Oncotype DX Breast DCIS Score. Ann Surg Oncol. 2019;26(10):3282–8.CrossRef Van Zee KJ, Zabor EC, Di Donato R, et al. Comparison of local recurrence risk estimates after breast-conserving surgery for DCIS: DCIS nomogram versus refined Oncotype DX Breast DCIS Score. Ann Surg Oncol. 2019;26(10):3282–8.CrossRef
20.
Zurück zum Zitat Yi M, Meric-Bernstam F, Kuerer HM, et al. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol. 2012;30(6):600–7.CrossRef Yi M, Meric-Bernstam F, Kuerer HM, et al. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol. 2012;30(6):600–7.CrossRef
21.
Zurück zum Zitat Fancellu A, Turner RM, Dixon JM, Pinna A, Cottu P, Houssami N. Meta-analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ. Br J Surg. 2015;102(8):883–93.CrossRef Fancellu A, Turner RM, Dixon JM, Pinna A, Cottu P, Houssami N. Meta-analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ. Br J Surg. 2015;102(8):883–93.CrossRef
22.
Zurück zum Zitat Wei S, Kragel CP, Zhang K, Hameed O. Factors associated with residual disease after initial breast-conserving surgery for ductal carcinoma in situ. Hum Pathol. 2012;43(7):986–93.CrossRef Wei S, Kragel CP, Zhang K, Hameed O. Factors associated with residual disease after initial breast-conserving surgery for ductal carcinoma in situ. Hum Pathol. 2012;43(7):986–93.CrossRef
23.
Zurück zum Zitat Mokbel K, Choy C, Leris C, et al. Predictors of positive margins after local excision of ductal carcinoma in situ. Am J Surg. 2001;181(2):91–5.CrossRef Mokbel K, Choy C, Leris C, et al. Predictors of positive margins after local excision of ductal carcinoma in situ. Am J Surg. 2001;181(2):91–5.CrossRef
24.
Zurück zum Zitat Hassan RA, Maesaka JY, Ricci MD, et al. Predictive factors for positive surgical margins in the treatment of breast ductal carcinoma in situ. J Cancer Res Ther. 2016;12(2):995–8.CrossRef Hassan RA, Maesaka JY, Ricci MD, et al. Predictive factors for positive surgical margins in the treatment of breast ductal carcinoma in situ. J Cancer Res Ther. 2016;12(2):995–8.CrossRef
25.
Zurück zum Zitat Melstrom LG, Melstrom KA, Wang EC, Pilewskie M, Winchester DJ. Ductal carcinoma in situ: size and resection volume predict margin status. Am J Clin Oncol. 2010;33(5):438–42.CrossRef Melstrom LG, Melstrom KA, Wang EC, Pilewskie M, Winchester DJ. Ductal carcinoma in situ: size and resection volume predict margin status. Am J Clin Oncol. 2010;33(5):438–42.CrossRef
26.
Zurück zum Zitat Alves-Ribeiro L, Osório F, Amendoeira I, Fougo JL. Positive margins prediction in breast cancer conservative surgery: assessment of a preoperative web-based nomogram. Breast. 2016;28:167–73.CrossRef Alves-Ribeiro L, Osório F, Amendoeira I, Fougo JL. Positive margins prediction in breast cancer conservative surgery: assessment of a preoperative web-based nomogram. Breast. 2016;28:167–73.CrossRef
27.
Zurück zum Zitat Walsh SM, Brennan SB, Zabor EC, et al. Does Breast density increase the risk of re-excision for women with breast cancer having breast-conservation therapy? Ann Surg Oncol. 2019;26(13):4246–53.CrossRef Walsh SM, Brennan SB, Zabor EC, et al. Does Breast density increase the risk of re-excision for women with breast cancer having breast-conservation therapy? Ann Surg Oncol. 2019;26(13):4246–53.CrossRef
28.
Zurück zum Zitat Valero MG, Mallory MA, Losk K, Tukenmez M, Hwang J, Camuso K, Bunnell C, King T, Golshan M. Surgeon variability and factors predicting for reoperation following breast-conserving surgery. Ann Surg Oncol. 2018;25(9):2573–8.CrossRef Valero MG, Mallory MA, Losk K, Tukenmez M, Hwang J, Camuso K, Bunnell C, King T, Golshan M. Surgeon variability and factors predicting for reoperation following breast-conserving surgery. Ann Surg Oncol. 2018;25(9):2573–8.CrossRef
30.
Zurück zum Zitat Morrow M, Van Zee K, Solin L, et al. SSO-ASTRO-ASCO Consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in-situ. Ann Surg Oncol. 2016;23(12):3801–910.CrossRef Morrow M, Van Zee K, Solin L, et al. SSO-ASTRO-ASCO Consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in-situ. Ann Surg Oncol. 2016;23(12):3801–910.CrossRef
Metadaten
Titel
Mastectomy or Margin Re-excision? A Nomogram for Close/Positive Margins After Lumpectomy for DCIS
verfasst von
Catarina Martins Maia, MD
Cleo Siderides, BA
Shabnam Jaffer, MD
Christina Weltz, MD
Sarah Cate, MD
Soojin Ahn, MD
Susan Boolbol, MD
Meng Ru, MS
Erin Moshier, MS
Elisa Port, MD
Hank Schmidt, MD, PhD
Publikationsdatum
22.01.2022
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2022
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-021-11293-3

Weitere Artikel der Ausgabe 6/2022

Annals of Surgical Oncology 6/2022 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Recycling im OP – möglich, aber teuer

05.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.